Stoke Therapeutics Inc (STOK) reports promising advancements in its Dravet syndrome program and strategic partnerships, ...

Stoke Therapeutics Inc (NASDAQ:STOK) is set to release its Q2 2025 earnings on Aug 12, 2025. The consensus estimate for Q2 ...

Has striker Ollie Palmer just earned himself the most unlikely of Wrexham reprieves with two goals against Hull City?

Wrexham striker Ollie Palmer scored two goals in the space of a minute in stoppage time then converted one of the team's ...

Phil Parkinson's side beat fellow EFL Championship side Hull City on penalties at the STok Cae Ras on Tuesday evening (July 13). Elliot Lee had put the Reds in front (31') before the Tigers equalised ...

Two late Ollie Palmer goals see Wrexham come from behind to force penalties in the Carabao Cup first round and beat Hull in ...

Phil Parkinson's side beat fellow EFL Championship side Hull City on penalties at the STok Cae Ras on Tuesday evening (July ...

Analysts have given Stoke Therapeutics a total of 3 ratings, with the consensus rating being Buy. The average one-year price target is $29.0, indicating a potential 121.37% upside.

STOK, the landmark 60,000 sq ft office building in Stockport, has completed the fit out of its final phase of 'plug and play' ...

Wrexham have taken a significant step toward boosting their stadium’s capacity, having officially submitted a planning ...

Stoke Therapeutics ( ($STOK) ) has released its Q2 earnings. Here is a breakdown of the information Stoke Therapeutics presented to its investors.

Wrexham forward Ryan Hardie says he apologised to his team-mates for missing a "crucial" chance at Southampton that might ...